Effectiveness and Safety of High Dose Tigecycline for the Treatment of Severe Infections: A Systematic Review and Meta-Analysis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effectiveness and Safety of High Dose Tigecycline for the Treatment of Severe Infections: A Systematic Review and Meta-Analysis
Authors
Keywords
-
Journal
ADVANCES IN THERAPY
Volume 37, Issue 3, Pages 1049-1064
Publisher
Springer Science and Business Media LLC
Online
2020-02-01
DOI
10.1007/s12325-020-01235-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- High incidence of MDR and XDR Pseudomonas aeruginosa isolates obtained from patients with ventilator-associated pneumonia in Greece, Italy and Spain as part of the MagicBullet clinical trial
- (2019) Astrid Pérez et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Epidemiology and Treatment of Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa Infections
- (2019) Juan P. Horcajada et al. CLINICAL MICROBIOLOGY REVIEWS
- Efficacy and safety of tigecycline in treatment of pneumonia caused by MDR Acinetobacter baumannii: a systematic review and meta-analysis
- (2019) Hekun Mei et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Treatment of infections caused by multidrug-resistant Gram-negative bacteria: report of the British Society for Antimicrobial Chemotherapy/Healthcare Infection Society/British Infection Association Joint Working Party†
- (2018) Peter M Hawkey et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- High-dose tigecycline for the treatment of nosocomial carbapenem-resistant Klebsiella pneumoniae bloodstream infections
- (2018) Ting-Ting Geng et al. MEDICINE
- Incidence and outcomes of multidrug-resistant gram-negative bacteria infections in intensive care unit from Nepal- a prospective cohort study
- (2018) Shraddha Siwakoti et al. Antimicrobial Resistance and Infection Control
- Best tigecycline dosing for treatment of infections caused by multidrug-resistant pathogens in critically ill patients with different body weights
- (2018) Mohamed M. Ibrahim et al. Drug Design Development and Therapy
- High incidence of pandrug-resistant Acinetobacter baumannii isolates collected from patients with ventilator-associated pneumonia in Greece, Italy and Spain as part of the MagicBullet clinical trial
- (2017) J Nowak et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- The efficacy and safety of tigecycline for the treatment of bloodstream infections: a systematic review and meta-analysis
- (2017) Jian Wang et al. Annals of Clinical Microbiology and Antimicrobials
- Clinical and Epidemiological Significance of Carbapenem Resistance in Acinetobacter baumannii Infections
- (2016) Ruthy Tal-Jasper et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efficacy and Safety of Tigecycline for Patients with Hospital-Acquired Pneumonia
- (2016) Li Xu et al. CHEMOTHERAPY
- Tigecycline Treatment for Carbapenem-Resistant Enterobacteriaceae Infections
- (2016) Wentao Ni et al. MEDICINE
- ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
- (2016) Jonathan AC Sterne et al. BMJ-British Medical Journal
- ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
- (2016) Jonathan AC Sterne et al. BMJ-British Medical Journal
- The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
- (2015) Brian Hutton et al. ANNALS OF INTERNAL MEDICINE
- Antimicrobial resistance: a priority for global health action
- (2015) Arthur Chioro et al. BULLETIN OF THE WORLD HEALTH ORGANIZATION
- Efficacy and safety of tigecycline for the treatment of severe infectious diseases: an updated meta-analysis of RCTs
- (2015) Fengcai Shen et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Multidrug-resistant Gram-negative bacteria: a product of globalization
- (2015) P.M. Hawkey JOURNAL OF HOSPITAL INFECTION
- Characteristics, risk factors and outcomes of carbapenem-resistant Klebsiella pneumoniae infections in the intensive care unit
- (2015) Konstantinos Z. Vardakas et al. JOURNAL OF INFECTION
- In vitro activity of potential old and new drugs against multidrug-resistant gram-negatives
- (2015) Camila Rizek et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Infections Caused by Resistant Gram-Negative Bacteria: Epidemiology and Management
- (2015) Keith S. Kaye et al. PHARMACOTHERAPY
- Influence of carbapenem resistance on mortality of patients with Pseudomonas aeruginosa infection: a meta-analysis
- (2015) Qianqian Liu et al. Scientific Reports
- Tigecycline for carbapenem-resistant Klebsiellapneumoniaeinfections in the intensive care unit
- (2015) Konstantinos Z. Vardakas et al. Infectious Diseases
- Tigecycline: a critical safety review
- (2014) Quanhathai Kaewpoowat et al. Expert Opinion On Drug Safety
- Antimicrobial resistance: impact on clinical and economic outcomes and the need for new antimicrobials
- (2014) Abrar K Thabit et al. EXPERT OPINION ON PHARMACOTHERAPY
- Effectiveness and safety of high-dose tigecycline-containing regimens for the treatment of severe bacterial infections
- (2014) Matthew E. Falagas et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Carbapenemases in Gram-Negative Bacteria: Laboratory Detection and Clinical Significance
- (2014) Branka Bedenić et al. Biomed Research International
- A new strategy to fight antimicrobial resistance: the revival of old antibiotics
- (2014) Nadim Cassir et al. Frontiers in Microbiology
- Randomized Phase 2 Trial To Evaluate the Clinical Efficacy of Two High-Dosage Tigecycline Regimens versus Imipenem-Cilastatin for Treatment of Hospital-Acquired Pneumonia
- (2013) Julio Ramirez et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases
- (2013) L Silvia Munoz-Price et al. LANCET INFECTIOUS DISEASES
- Tigecycline therapy for infections due to carbapenemase-producing Klebsiella pneumoniae in critically ill patients
- (2013) B. Balandin Moreno et al. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
- KPC - 3 Klebsiella pneumoniaeST258 clone infection in postoperative abdominal surgery patients in an intensive care setting: analysis of a case series of 30 patients
- (2013) Paola Di Carlo et al. BMC Anesthesiology
- Influence of Multidrug Resistance and Appropriate Empirical Therapy on the 30-Day Mortality Rate of Pseudomonas aeruginosa Bacteremia
- (2012) Laura Morata et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Excess Deaths Associated With Tigecycline After Approval Based on Noninferiority Trials
- (2012) P. Prasad et al. CLINICAL INFECTIOUS DISEASES
- Pharmacokinetic and pharmacodynamic evaluation of tigecycline
- (2011) Helen Giamarellou et al. Expert Opinion on Drug Metabolism & Toxicology
- Efficacy and safety of tigecycline: a systematic review and meta-analysis
- (2011) Dafna Yahav et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Efficacy and safety of tigecycline for the treatment of infectious diseases: a meta-analysis
- (2011) Efthimia Tasina et al. LANCET INFECTIOUS DISEASES
- Hospital-Acquired Infections Due to Gram-Negative Bacteria
- (2010) Anton Y. Peleg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Attributable Hospital Cost and Length of Stay Associated with Health Care-Associated Infections Caused by Antibiotic-Resistant Gram-Negative Bacteria
- (2009) P. D. Mauldin et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Baseline in vitro Activity of Tigecycline among Key Bacterial Pathogens Exhibiting Multidrug Resistance
- (2008) Deborah C. Draghi et al. CHEMOTHERAPY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started